Syngenta is withdrawing from Australia's paraquat market after new regulatory restrictions made the herbicide commercially unviable, leaving farmers dependent on Chinese generic alternatives and raising questions about supply chain reliability.
The company announced Friday it's ending paraquat sales in Australia and New Zealand following the Australian Pesticides and Veterinary Medicines Authority's decision last month to impose new limits and conditions on the controversial herbicide. The APVMA stopped short of an outright ban, finding no evidence the chemical increased Parkinson's disease risk when used safely under its significant restrictions.
Regulatory Burden Drives Exit
Syngenta's departure wasn't a safety decision. It's an economic one. "Regulatory constraints, combined with a highly complex and increasingly expensive supply chain, have made the paraquat herbicide products commercially unviable," managing director David Van Ryswyk said. The company's global production already ceased at the end of June, following its March announcement that it would close its UK plant.
Four months ago, Syngenta committed to supplying Australian farmers through a third-party manufacturer. That arrangement is now ending as well. "Dedicating significant resources to unprofitable legacy products is no longer sustainable," Van Ryswyk said. "Paraquat has been a highly valued productivity and conservation tool for many Australian and New Zealand growers. This decision, while difficult, allows us to redirect our resources."
Chinese Generics Fill the Gap
Generic versions of paraquat will remain available in Australia, but the supply chain shift concerns farmers. Western Victorian farmer and Grain Producers Australia spokesman Andrew Weidemann said Syngenta's exit created uncertainty. "Syngenta has been the stable foundation of this market for decades," he said.
There's no shortage of paraquat chemicals available, Weidemann noted, but "unfortunately, most of them [are] coming out of China." The shift from a Western manufacturer with established quality controls to predominantly Chinese suppliers represents a significant change for an industry that's relied on Syngenta's product for decades. "[Syngenta's] withdrawal leaves some important questions about what happens next," Weidemann said.
Industry Bears Compliance Costs
Weidemann raised concerns that Syngenta's departure would complicate implementing the APVMA's label changes. "Some of the changes in grams active and the withholding periods on late applications in crop, that work will fall clearly on the feet of the industry," he said. The cost of compliance won't disappear with Syngenta. "So it's going to be a cost and … that's going to be something that we as the industry will have to work through."
Syngenta said it would manage the phase-out in strict alignment with the APVMA's designated sell-out and use-by timelines. The APVMA said it doesn't comment on individual companies' commercial decisions.
Why This Matters:
Syngenta's exit demonstrates how regulatory complexity can eliminate established suppliers from markets, even when products aren't banned outright. Australian farmers now face a supply chain dominated by Chinese generic manufacturers, raising questions about quality consistency and long-term reliability. The compliance burden for APVMA's label changes shifts entirely to the agricultural industry and remaining suppliers, creating costs that'll ultimately flow through to producers. When Western manufacturers find markets commercially unviable due to regulatory overhead, the alternatives aren't necessarily safer or better regulated—they're just produced elsewhere under different standards. This pattern repeats across agricultural inputs: regulations designed to manage risk sometimes just offshore production to jurisdictions with less oversight.